SHL2 Antibody

What is SHL2 Antibody and what are its primary research applications?

SHL2 Antibody is a rabbit polyclonal antibody that recognizes the SHL2 protein in Oryza sativa (rice). It is primarily used for Western Blot (WB) applications in plant molecular biology research. This unconjugated antibody is generated using recombinant protein of Oryza sativa OsRDR6 as the immunogen and has undergone affinity purification to enhance specificity .

The methodological approach for using this antibody in Western Blot involves:

• Sample preparation from plant tissue with appropriate extraction buffers

• Protein separation via SDS-PAGE

• Transfer to an appropriate membrane (PVDF or nitrocellulose)

• Blocking with 5% non-fat milk or BSA

• Incubation with the SHL2 antibody at appropriate dilution

• Detection using standard secondary antibody systems

What is the recommended dilution range for SHL2 Antibody in Western Blot applications?

For optimal results in Western Blot applications, the SHL2 Antibody should be used at a dilution range of 1:500-1:2,000 . The exact dilution should be determined empirically for each experimental setup, considering factors such as:

A titration experiment is recommended when first using the antibody, testing several dilutions within the recommended range to determine optimal signal-to-noise ratio for your specific experimental conditions.

What is the molecular weight of the target protein detected by SHL2 Antibody?

• Post-translational modifications may cause shifts in apparent molecular weight

• Proteolytic degradation might produce smaller fragments

• Sample preparation conditions can affect protein migration patterns

Always include appropriate molecular weight markers and positive controls when performing Western Blot analysis to accurately identify the target protein.

How should SHL2 Antibody be stored and handled to maintain its activity?

To maintain optimal activity of the SHL2 Antibody, follow these methodological guidelines:

• Storage temperature: Store at -20°C for long-term storage

• Working aliquots: Prepare small aliquots to avoid repeated freeze-thaw cycles

• Thawing procedure: Thaw on ice and centrifuge briefly before opening

• Working dilutions: Store at 4°C for up to one week; avoid prolonged storage of diluted antibody

• Contamination prevention: Use sterile technique when handling the antibody

Following these protocols will help maintain antibody performance and extend its useful life for experimental applications.

What controls should be used when working with SHL2 Antibody?

Implementing proper controls is essential for validating SHL2 Antibody results. The following methodological approach is recommended:

These controls should be systematically incorporated into experimental design to ensure reliable interpretation of results obtained with the SHL2 Antibody.

How can SHL2 Antibody be validated for specificity in plant tissue samples?

Validating the specificity of SHL2 Antibody in plant tissues requires a multi-faceted approach:

• Genetic validation: Compare wild-type plants with SHL2 knockout/knockdown lines to confirm absence of signal in mutants

• Recombinant protein validation: Express tagged recombinant SHL2 and confirm detection by both anti-tag and SHL2 antibodies

• Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry to confirm pulled-down protein identity

• Cross-reactivity assessment: Test antibody against related plant proteins to evaluate potential cross-reactivity

• Epitope blocking: Pre-incubate antibody with immunizing peptide to confirm signal extinction

This comprehensive validation protocol ensures that observed signals genuinely represent SHL2 protein rather than non-specific interactions, which is particularly important given the complex nature of plant proteomes.

What troubleshooting approaches are recommended when SHL2 Antibody produces inconsistent results?

When encountering inconsistent results with SHL2 Antibody, implement this systematic troubleshooting methodology:

• Sample preparation assessment:

  • Verify complete protein denaturation and reduction

  • Ensure protease inhibitors are fresh and effective

  • Test alternative extraction buffers suitable for plant tissues

• Protocol optimization:

  • Adjust antibody concentration (1:500-1:2,000 range)

  • Modify incubation time and temperature

  • Test alternative blocking reagents (BSA vs. non-fat milk)

  • Evaluate different membrane types (PVDF vs. nitrocellulose)

• Detection system evaluation:

  • Check secondary antibody compatibility and freshness

  • Test alternative detection methods (chemiluminescence vs. fluorescence)

  • Adjust exposure times to optimize signal-to-noise ratio

• Reagent quality control:

  • Prepare fresh working solutions of all reagents

  • Check pH of all buffers

  • Verify antibody storage conditions

Implementing this structured approach will help identify and resolve technical issues that may be contributing to inconsistent results.

How can epitope mapping be performed for SHL2 Antibody?

Epitope mapping for SHL2 Antibody can be methodically approached through several complementary techniques:

• Peptide array analysis:

  • Synthesize overlapping peptides spanning the SHL2 sequence

  • Probe array with SHL2 Antibody

  • Identify reactive peptides to narrow epitope location

• Deletion mutant analysis:

  • Generate series of SHL2 deletion constructs

  • Express and purify truncated proteins

  • Test antibody binding to identify region containing epitope

  This approach is similar to the method used for mapping hs2dAb B99 and hs2dAb B120 epitopes on Shoc2, where deletion mutants helped identify the recognition region .

• Site-directed mutagenesis:

  • Introduce point mutations in candidate epitope regions

  • Assess impact on antibody binding

  • Identify critical residues for antibody recognition

• Hydrogen-deuterium exchange mass spectrometry:

  • Compare deuterium uptake patterns of free vs. antibody-bound protein

  • Regions protected from exchange likely represent epitope regions

This methodological framework provides a comprehensive approach to defining the specific epitope recognized by SHL2 Antibody, which can inform experimental design and interpretation.

What methods can be used to quantify the binding affinity of SHL2 Antibody to its target?

Several methodological approaches can be employed to quantify SHL2 Antibody binding affinity:

• Bio-layer interferometry (BLI):

  • Immobilize purified SHL2 protein onto biosensor

  • Expose to varying concentrations of antibody

  • Measure association and dissociation rates

  • Calculate KD value from kinetic parameters

  This approach was successfully used to determine binding kinetics for hs2dAb B99 and hs2dAb B120 antibodies, yielding KD values in the nanomolar range (14.4 nM and 516 nM, respectively) .

• Surface plasmon resonance (SPR):

  • Immobilize antibody or antigen on sensor chip

  • Flow varying concentrations of binding partner

  • Monitor real-time binding kinetics

  • Calculate association (ka) and dissociation (kd) rate constants

• Isothermal titration calorimetry (ITC):

  • Measure heat released/absorbed during binding

  • Determine thermodynamic parameters (ΔH, ΔS, ΔG)

  • Calculate binding stoichiometry and affinity

• Enzyme-linked immunosorbent assay (ELISA):

  • Coat plates with purified SHL2 protein

  • Incubate with serial dilutions of antibody

  • Measure binding using appropriate detection system

  • Generate binding curve to calculate apparent KD

These quantitative methodologies provide valuable information about antibody-antigen interaction strength, which is crucial for optimizing experimental conditions.

How does sample preparation affect the binding efficiency of SHL2 Antibody?

Sample preparation significantly impacts SHL2 Antibody binding efficiency through several mechanisms:

The methodological approach to optimize sample preparation should include:

• Systematic testing of extraction conditions

• Comparison of different buffer compositions

• Evaluation of denaturation methods

• Assessment of reducing agent requirements

This systematic optimization will help ensure consistent and specific detection of SHL2 protein across experiments.

Can SHL2 Antibody be used for immunoprecipitation studies in rice research?

While the product specifications primarily list Western Blot as the validated application , immunoprecipitation (IP) may be feasible with methodological adaptations:

• Pre-clearing protocol:

  • Incubate rice tissue lysate with protein A/G beads

  • Remove beads to reduce non-specific binding

  • Proceed with antibody incubation

• Antibody binding optimization:

  • Test different antibody amounts (2-10 μg per 500 μg total protein)

  • Optimize incubation time (2 hours to overnight)

  • Compare direct vs. indirect capture methods

• Wash stringency balancing:

  • Start with low-stringency buffers (150 mM NaCl)

  • Progressively increase stringency if background is high

  • Monitor target protein retention throughout optimization

• Elution method selection:

  • Compare boiling in SDS buffer vs. acid elution vs. peptide competition

  • Select method that maximizes target recovery while minimizing contaminants

• Validation approach:

  • Confirm pulled-down protein identity by Western Blot

  • Consider mass spectrometry for comprehensive interactome analysis

This methodological framework provides a starting point for adapting SHL2 Antibody for immunoprecipitation studies, which would be valuable for identifying SHL2 interaction partners in rice.

How can cross-reactivity with related proteins be assessed when using SHL2 Antibody?

To rigorously assess potential cross-reactivity of SHL2 Antibody with related proteins, implement this methodological approach:

• In silico analysis:

  • Identify proteins with sequence similarity to SHL2

  • Predict potential cross-reactive epitopes

  • Prioritize candidates for experimental testing

• Recombinant protein panel testing:

  • Express and purify SHL2-related proteins

  • Perform Western Blot analysis

  • Quantify relative binding to each protein

• Knockout/knockdown validation:

  • Test antibody in SHL2-deficient plant tissues

  • Any remaining signal may indicate cross-reactivity

  • Identify bands for further characterization

• Competitive binding assays:

  • Pre-incubate antibody with related proteins

  • Assess impact on SHL2 detection

  • Quantify competition as indicator of cross-reactivity

• Protein array screening:

  • Test antibody on protein microarrays containing multiple plant proteins

  • Identify any unexpected binding partners

  • Follow up with validation experiments

This approach is similar to specificity testing methodologies used for SH2 domain antibodies, where antibodies were tested against panels of related proteins to confirm monospecificity .

Can SHL2 Antibody be adapted for intracellular visualization techniques?

Adapting SHL2 Antibody for intracellular visualization requires methodological considerations:

• Fixation optimization:

  • Test different fixatives (paraformaldehyde, methanol, acetone)

  • Optimize fixation time and temperature

  • Evaluate impact on epitope preservation

• Permeabilization protocol development:

  • Compare detergents (Triton X-100, saponin, digitonin)

  • Adjust concentration and incubation time

  • Balance membrane permeabilization with antigen preservation

• Antibody concentration adjustment:

  • Start with 1:100-1:500 dilutions (higher than WB)

  • Perform titration experiments

  • Optimize for specific signal with minimal background

• Signal amplification strategies:

  • Evaluate tyramide signal amplification

  • Consider fluorescently-labeled secondary antibodies

  • Test biotin-streptavidin systems for enhanced detection

• Validation controls:

  • Include peptide competition controls

  • Compare with SHL2-GFP fusion protein localization

  • Use SHL2 knockout/knockdown tissues as negative controls

This approach draws on principles used for intracellular antibody (intrabody) applications, where antibodies have been successfully adapted for visualization of endogenous proteins using microscopy techniques .

How might SHL2 Antibody be used to study protein-protein interactions in signaling pathways?

SHL2 Antibody can be methodically applied to study protein-protein interactions through several complementary approaches:

• Co-immunoprecipitation:

  • Use SHL2 Antibody to pull down protein complexes

  • Identify interacting partners via Western Blot or mass spectrometry

  • Compare interaction profiles under different conditions

  This approach is analogous to how high-affinity antibodies were shown to efficiently precipitate known interacting partners in scaffold protein complexes .

• Proximity ligation assay (PLA):

  • Use SHL2 Antibody with antibodies against putative interaction partners

  • Visualize interactions as fluorescent spots when proteins are in proximity (<40nm)

  • Quantify interaction frequency in different cellular compartments

• Bimolecular fluorescence complementation (BiFC) validation:

  • Express SHL2 and candidate partners as fusion proteins with split fluorescent protein fragments

  • Validate antibody-identified interactions through complementation signal

  • Use antibody to confirm expression levels of fusion proteins

• Sequential immunoprecipitation:

  • First IP with SHL2 Antibody

  • Elute complexes and perform second IP with antibody against interacting protein

  • Identify proteins present in both IPs to confirm direct interactions

This methodological framework provides multiple lines of evidence for protein-protein interactions involving SHL2, enabling research into its signaling functions in rice.

What considerations apply when using SHL2 Antibody in comparative studies across plant species?

When extending SHL2 Antibody use to comparative studies across plant species, implement this methodological approach:

• Cross-reactivity pre-assessment:

  • Perform sequence alignment of SHL2 homologs across target species

  • Identify conservation in potential epitope regions

  • Predict likelihood of antibody recognition

• Gradual validation protocol:

  • Begin with closely related species (e.g., other Oryza species)

  • Progressively test more distantly related plants

  • Validate each new species individually

• Signal verification:

  • Confirm molecular weight differences based on sequence data

  • Use genetic tools (RNAi, CRISPR) when available to validate specificity

  • Consider epitope-tagged overexpression for positive controls

• Optimized extraction methods:

  • Adapt tissue lysis protocols for each species

  • Account for differences in secondary metabolites and proteases

  • Standardize protein quantification across samples

• Data normalization strategy:

  • Identify conserved housekeeping proteins across species

  • Develop normalization strategy for cross-species comparisons

  • Consider relative affinity differences in quantitative comparisons

This systematic approach enables reliable comparative studies while accounting for potential variations in antibody performance across different plant species.

How can SHL2 Antibody be used in combination with other antibodies for multiplex analysis?

Implementing multiplex analysis with SHL2 Antibody requires these methodological considerations:

• Antibody compatibility assessment:

  • Ensure host species differences between primary antibodies

  • Verify non-overlapping detection systems

  • Test for cross-reactivity between secondary antibodies

• Sequential detection protocol:

  • Strip and reprobe membranes for Western Blot

  • Start with lower abundance targets

  • Use different fluorophores for simultaneous detection

  Protein	Primary Antibody	Secondary Antibody	Detection Wavelength
  SHL2	Rabbit anti-SHL2	Anti-rabbit Alexa 488	519 nm (green)
  Protein X	Mouse anti-Protein X	Anti-mouse Alexa 568	603 nm (red)
  Protein Y	Goat anti-Protein Y	Anti-goat Alexa 647	665 nm (far-red)

• Multiplexed immunoprecipitation:

  • Use antibody cocktails for co-IP experiments

  • Separate detection of multiple proteins in single IP sample

  • Compare with individual IP results to confirm specificity

• Image acquisition optimization:

  • Adjust exposure settings for each fluorophore

  • Account for potential bleed-through between channels

  • Use appropriate filter sets to minimize spectral overlap

This approach enables simultaneous analysis of multiple proteins, providing insights into complex relationships between SHL2 and other components of plant cellular pathways.

What emerging technologies might enhance the utility of SHL2 Antibody in future research?

Several emerging methodological approaches could expand SHL2 Antibody applications:

• Single-domain antibody derivatives:

  • Develop nanobodies or single-domain antibodies against SHL2

  • Enable live-cell imaging and functional modulation

  • Improve tissue penetration for whole-mount applications

  This approach draws inspiration from successful development of single-domain antibodies for other proteins, which showed nanomolar binding affinities and functional applications in cellular assays .

• Antibody-guided proximity labeling:

  • Conjugate SHL2 Antibody to promiscuous labeling enzymes (APEX2, TurboID)

  • Map proximal proteome of SHL2 in living cells

  • Identify transient interaction partners

• Super-resolution microscopy applications:

  • Adapt SHL2 Antibody for STORM/PALM techniques

  • Achieve nanoscale resolution of SHL2 localization

  • Reveal suborganellar distribution patterns

• Antibody-drug conjugates for targeted protein degradation:

  • Link SHL2 Antibody to proteolysis-targeting chimeras (PROTACs)

  • Enable selective degradation of SHL2 in research models

  • Study functional consequences of acute protein depletion

• CRISPr epitope tagging validation systems:

  • Use CRISPR to introduce tags at endogenous SHL2 locus

  • Compare antibody detection with tag detection

  • Validate antibody performance at endogenous expression levels

These innovative approaches represent the frontier of antibody technology and could significantly enhance the research utility of SHL2 Antibody in plant biology applications.